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Abstract
Introduction: The aim of this study was to determine which factors increase the risk of metabolic syndrome (MS) and its components in
obese children and adolescents.
Material and methods: In 78 obese children (42 girls, 36 boys), mean age 14.6 ± 3.5 years, blood pressure, total cholesterol, triglycerides,
HDL-cholesterol (HDL), insulin and glucose at fasting state as well as in OGTT were measured. Body mass index (BMI) Z-score, LDL-
cholesterol, and insulin resistance indices (FIGR, R-HOMA) were calculated.
Results: Metabolic syndrome was diagnosed in ten (12.8%) children. Hyperinsulinaemia was present in 42 (53.8%) subjects, increased
FIGR in eight (10.3%) and increased R-HOMA in 49 (62.3%). Significant correlations between BMI Z-score ≥ 2.5 and MS occurrence and its
components (hypertriglyceridaemia, isolated systolic and diastolic hypertension) were found. Hypertriglyceridaemia, low HDL and hy-
pertension, as well as MS occurrence, correlated significantly with stimulated hyperinsulinaemia and increased FIGR. Risk of hyperten-
sion was increased 5.6 times by fasting hyperinsulinaemia. Stimulated hyperinsulinaemia increased the risk of hypertriglyceridaemia
3.7 times, risk of low HDL 14.4 times and risk of MS 10.3 times. These risks did not change significantly when adjusted for BMI Z-score.
Conclusions: Our study results show that both BMI Z-score and OGTT stimulated hyperinsulinaemia are good predictors of MS occur-
rence in obese children and adolescents. The risk of dyslipidaemia and hypertension increase significantly with hyperinsulinaemia and
insulin resistance, with low HDL cholesterol being the most affected. (Pol J Endocrinol 2011; 62 (2): 102–108)
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Streszczenie
Wstęp: Celem pracy było określenie czynników ryzyka wystąpienia zespołu metabolicznego (MS, metabolic syndrome) i jego składowych
u otyłych dzieci i młodzieży.
Materiał i metody: U 78 dzieci z otyłością prostą (42 dziewczynek, 36 chłopców) w średnim wieku 14,6±3,5 lat oznaczono stężenia
cholesterolu całkowitego, triglicerydów, cholesterolu frakcji HDL (HDL), insuliny i glukozy na czczo i w OGTT, obliczono indeks masy
ciała (BMI, body mass index) i jego Z-score oraz wskaźniki insulinooporności (FIGR, R-HOMA). Dokonano 3-krotnych pomiarów ciśnienia
tętniczego.
Wyniki: Zespół metaboliczny rozpoznano u 10 (12,8%) dzieci, podwyższone stężenie insuliny na czczo odnotowano u 42 (53,8%), pod-
wyższony FIGR u 8 (10,3%), a podwyższony R-HOMA u 49 (62,3%) badanych. Wskaźnik masy ciała Z-score ≥ 2,5 był istotnie związany
z występowaniem MS oraz jego komponentów (hipertriglicerydemią, izolowanym nadciśnieniem skurczowym i rozkurczowym). Stwier-
dzono istotną korelację hipertriglicerydemii, niskiego stężenia HDL, nadciśnienia i występowania MS z hiperinsulinemią w OGTT i podwyż-
szonym FIGR. Ponadto ryzyko nadciśnienia było 5,6-krotnie wyższe u dzieci z hiperinsulinemią na czczo. Hiperinsulinemia w OGTT
zwiększała ryzyko wystąpienia hipertriglicerydemii 3,7-krotnie, ryzyko niskiego stężenia HDL — 14,4-krotnie, a ryzyko MS — 10,3-krot-
nie. Związki te nie zmieniły się istotnie po skorygowaniu dla BMI Z-score.
Wnioski: Stwierdzono, że zarówno BMI Z-score, jak i hiperinsulinemia w OGTT są dobrymi czynnikami prognostycznymi wystąpienia
MS u otyłych dzieci i młodzieży. Ryzyko wystąpienia nadciśnienia i dyslipidemii, a szczególnie niskiego stężenia HDL, wzrasta istotnie
u dzieci z hiperinsulinemią i insulinoopornością. (Endokrynol Pol 2011; 62 (2): 102–108)
Słowa kluczowe: insulinoporność, hiperinsulinemia, zespół metaboliczny, dzieci, młodzież
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Introduction
Obesity, the 21st century pandemic, affects more than
a billion people worldwide. In recent decades, a con-
stant and significant increase in overweight and obesi-
ty has been noted. Childhood obesity has reached epi-
demic proportions [1] and is associated with a wide
range of serious complications including increased prev-
alence of cardiovascular risk factors. The clustering of
these risk factors, known as metabolic syndrome (MS),
if present in children, predicts adult cardiovascular dis-
ease [2]. MS has a common background: insulin resis-
tance (IR). IR is an inappropriate metabolic response to
insulin (INS) action resulting in dysfunction in glucose
(GLU) metabolism. Together with compensatory hyper-
insulinaemia, IR can be responsible for the development
of several metabolic abnormalities: dyslipidaemia, type
2 diabetes, arterial hypertension and increased risk of
cardiovascular disease [3]. However, heterogeneity ex-
ists among obese individuals with respect to INS sensi-
tivity and risk of IR-associated metabolic abnormalities
[4]. It is believed that obesity, especially with central fat
distribution, is the state that promotes IR, particularly
in genetically predisposed subjects [3]. An increased ac-
cumulation of intramyocellular lipid as well as visceral
fat, that can be a source of increased release of free fatty
acids into portal blood, may play a crucial role in obesi-
ty-related IR [3, 5].
The aim of our study was to evaluate whether MS risk,
and the risk of its components, is associated with a degree
of obesity, or rather with hyperinsulinaemia and IR.
Material and methods
As the centre specialising in paediatric obesity and en-
docrinology, we studied a group of obese children and
adolescents who were consecutively referred by their
family physicians for obesity evaluation and treatment.
The inclusion criteria were age above 10 years and no
endocrine or syndromal disorders. Seventy eight pa-
tients (and their parents or guardians) gave informed
consent to participate in the study (42 girls and 36 boys,
mean age 14.6 ± 3.5 years range 10–18 years). The study
was approved by the Local Ethics Committee of the
Medical University of Silesia.
For every participant, height, weight and waist cir-
cumference (WC) were recorded and pubertal devel-
opment according to Tanner stage was assessed by the
same person (M F-P). Eleven (14%) children were pre-
pubertal (Tanner stage 1) and 67 (86%) had entered
puberty (Tanner stage ≥ 2). Weight was measured to
the nearest 0.1 kg on a medical balanced scale. Height
was measured to the nearest 0.1 cm with a wall-mount-
ed stadiometer. Body mass index (BMI) was calculated
and obesity was defined according to BMI above the
97th percentile on Polish charts [6]. In every child, BMI
standard deviation score (BMI Z-score) was also deter-
mined [7,8]. Severity of obesity was classified as mild
(BMI Z-score £ 1.99), moderate (BMI Z-score 2.0–2.49),
severe (BMI Z-score 2.5–2.99) or morbid (BMI Z-score
≥ 3.0) [9]. WC measurement was taken at the level of
umbilicus with nonelastic flexible tape and plotted on
a percentile chart [10]. Blood pressure (BP) was mea-
sured three times, on the right arm, in the seated posi-
tion, using a sphygmomanometer, and the mean of the
three measurements was calculated. In all subjects, se-
rum fasting GLU and INS levels were measured and
oral GLU tolerance test (OGTT) (1.75 g/kg of body
weight of oral GLU, max 75 g) was performed. Fasting
INS to GLU ratio (FIGR) and homeostatic model assess-
ment of IR [R-HOMA, fasting GLU (mmol/L) × fasting
INS (mIU/L)/22.5] were calculated as indices of IR [11].
Serum total cholesterol (TC), triglycerides (TG) and
HDL-cholesterol (HDL) concentrations were deter-
mined and LDL-cholesterol (LDL) level was calculated
using Friedewald’s equation [12].
Biochemical parameters were measured using
chemical procedures in a dimension analyser (Dade Be-
hring). TG and TC levels were analysed enzymatically,
and HDL concentration was measured by direct proce-
dure using synthetic polymer and detergent (SPD pro-
cedure — Daichi). Insulin tests were performed using
chemiluminescent immunoassay by Immulite 2000 anal-
yser (DPC).
The levels of TG, HDL, GLU and BP were consid-
ered abnormal and MS was diagnosed according to In-
ternational Diabetes Foundation (IDF) criteria [13]. TC
level ≥ 200 mg/dL and LDL ≥ 130 mg/dL were consid-
ered as elevated [14]. Fasting and OGTT stimulated
hyperinsulinaemia was diagnosed when fasting INS
exceeded 15 mIU/mL and INS during OGTT was high-
er than 150 mIU/mL, respectively [15]. The child was
considered to be insulin resistant if FIGR exceeded
0.3 or/and R-HOMA was above 2.5 [11, 16].
For statistical analysis, a Statistica 6.0 PL program
was used. All values were expressed as mean/median
and standard deviation/interquartile range. Correlation
analysis was performed using Spearman’s correlation
coefficient for non-normally distributed samples and
Gamma correlation for non-normal distributions with
many tied ranks. The associations between hyperinsuli-
naemia and IR and metabolic disturbances, hyperten-
sion as well as MS were estimated by univariate analy-
sis and multivariate logistic regression analysis after
adjusting for BMI Z-score. The univariate logistic re-
gression analysis was also performed for estimation of
relationship between the degree of obesity and MS and
its components. A p value < 0.05 was considered to be
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statistically significant and 0.05 < p < 0.1 was consid-
ered as a trend toward statistical significance.
Results
In all studied children, BMI was above the 97th percen-
tile for age and sex according to Polish criteria [6]. Met-
abolic syndrome was diagnosed in ten (12.8%) obese
subjects. All but six (7.7%) of the children studied had
at least one component of MS. Dyslipidaemia was not-
ed in 34 (43.6%) obese children. An abnormal fasting
GLU level was found in six (7.7%) and impaired GLU
tolerance in 11 (14.3%) individuals. Hypertension was
diagnosed in 12 (15.4%) children. In 42 (53.8%) obese
children fasting and/or OGTT stimulated hyperinsuli-
naemia was present. Fasting INS concentration was in-
creased in 32 (41%) subjects, and INS level in OGTT
above 150 mIU/mL was noted in 27 (34.6%) children. In
17 (21.8%) studied individuals, both fasting and OGTT
stimulated INS levels were elevated. FIGR exceeded
0.3 in eight (10.3%) individuals and in 49 (62.3%) stud-
ied children increased R-HOMA was found.
Since no significant difference was found in all the
studied parameters between obese girls and boys, in fur-
ther analysis all the children were studied as one group.
Correlations of BMI Z-score with metabolic distur-
bances, hypertension and MS are presented in Table I.
BMI Z-score ranged from 1.68 to 3.55 (median: 2.37 ±
± 0.81). A significant linear correlation of BMI Z-score
with systolic and diastolic BP was found (r = 0.3; p = 0.007;
r = 0.3; p = 0.01, respectively). There were also signifi-
cant correlations between BMI Z-score and fasting INS
concentration (r = 0.23; p = 0.04) and R-HOMA (r = 0.23;
p = 0.04). BMI Z-score ≥ 2.0 correlated significantly with
MS only. There were significant correlations between
BMI Z-score ≥ 2.5 and hypertension as well as isolated
systolic and diastolic hypertension, hypertriglycer-
idaemia and MS. Moreover, BMI Z-score ≥ 3.0 corre-
lated significantly also with fasting hyperglycemia.
Significant linear correlations between fasting INS
and IR indices with TG (r = 0.31; p = 0.005, r = 0.27;
p = 0.02; r = 0.32; p = 0.004, respectively), systolic
(r = 0.31; p = 0.005; r = 0.33; p = 0.004; r = 0.29; p = 0.01,
respectively) and diastolic BP (r = 0.27; p = 0.02; r = 0.27;
p = 0.02; r = 0.25; p = 0.026, respectively) were found.
Correlations of hyperinsulinaemia and IR indices
with metabolic disturbances, hypertension and MS are
presented in Table II. MS occurrence correlated signifi-
cantly with elevated fasting and stimulated INS levels,
FIGR and R-HOMA. There were significant relation-
ships between OGTT stimulated hyperinsulinaemia and
increased FIGR and elevated TG concentration. The
decreased HDL level correlated significantly with in-
creased fasting and OGTT stimulated INS levels and
elevated FIGR. Fasting and stimulated hyperinsuli-
naemia and elevated IR indices (FIGR, R-HOMA) cor-
related significantly with hypertension and isolated di-
astolic hypertension. The isolated systolic hypertension
correlated also with increased fasting and stimulated
INS levels and R-HOMA. Increased GLU concentration
in 120’ of OGTT correlated significantly only with ele-
vated R-HOMA. There were no significant correlations
Table I. Correlation coefficients of BMI Z-score ≥ 2.0, ≥ 2.5, and ≥ 3.0 with metabolic disturbances, hypertension and
metabolic syndrome in 78 obese children and adolescents (42 girls, 36 boys)
Tabela I. Zależności pomiędzy BMI Z-score ≥ 2.0, ≥ 2.5, i ≥ 3.0 a zaburzeniami metabolicznymi, nadciśnieniem i zespołem
metabolicznym u 78 otyłych dzieci i młodzieży (42 dziewczęta, 36 chłopców)
BMI Z-score ≥ 2.0 BMI Z-score ≥ 2.5 BMI Z-score ≥ 3.0
TC ≥ 200 mg/dL –0.27 –0.27 0.05
TG ≥ 150 mg/dL 0.26 0.36* 0.48*
LDL ≥ 130 mg/dL –0.45* –0.02 0.29
Low HDL 0.20 0.27 0.18
Fasting GLU ≥ 100 mg/dL 0.43 0.25 0.60*
GLU 2-hours of OGTT ≥ 140 mg/dL 0.14 -0.03 0.23
Hypertension 0.20 0.45* 0.48*
Isolated diastolic hypertension 0.05 0.47* 0.58**
Isolated systolic hypertension 0.13 0.54** 0.53*
WC ≥ 90th 0.78*** 0.83*** 1.0*
Metabolic syndrome 0.66* 0.64** 0.75***
*p < 0.05; **p < 0.01; ***p < 0.001; TC — total cholesterol; TG — triglycerides; LDL — LDL cholesterol; low HDL — HDL cholesterol < 40 mg/dL in
children aged 10–16, < 40 mg/dL for boys above the age of 16, < 50 mg/dL for girls above the age of 16; GLU — glucose; OGTT — oral glucose
tolerance test; WC — waist circumference
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between fasting and stimulated hyperinsulinaemia and
IR indices and hypercholesterolaemia, increased fast-
ing GLU level and WC above the 90th percentile.
Selected unadjusted, and adjusted for BMI Z-score,
associations between fasting and stimulated hyperin-
sulinaemia, IR indices and dyslipidaemia, hypertension
and MS in obese children and adolescents are shown
in Table III.
In logistic regression analysis, the association be-
tween fasting hyperinsulinaemia and hypertension was
significant and the risk of increased BP was 5.6 times
higher in obese children with fasting hyperinsulinaemia
Table III. Selected unadjusted, and adjusted for BMI Z-score, association between hyperinsulinaemia and studied IR indices
and dyslipidaemia, hypertension and metabolic syndrome in 78 obese children and adolescents (42 girls, 36 boys)
Tabela III. Wybrane nieskorygowane i skorygowane dla BMI Z-score zależności pomiędzy hiperinsulinemią i wskaźnikami
insulinooporności a dyslipidemią, nadciśnieniem i zespołem metabolicznym u 78 otyłych dzieci i młodzieży (42 dziewczęta,
36 chłopców)
Unadjusted for BMI Z-score Adjusted for BMI Z-score
Fasting INS > 15 mIU/mL and isolated OR 7.3; 95% CI 1.4–38.3; p = 0.02 OR 6.2; 95% CI 1.16–33.2; p = 0.03
diastolic hypertension
Fasting INS > 15 mIU/mL and isolated OR 4.8; 95% CI 1.1–20.2; p = 0.03 OR 3.9; 95% CI 0.9–17.2; p = 0.07
systolic hypertension
Fasting INS > 15 mIU/mL and hypertension OR 5.6; 95% CI 1.4–23.3; p = 0.02 OR 4.7; 95% CI 1.1–20.2; p = 0.03
OGTT stimulated INS > 150 mIU/mL OR 3.7; 95% CI 1.2–11.5; p = 0.02 OR 3.6; 95% CI 1.1–11.2; p = 0.03
and TG ≥ 150 mg/dL
OGTT stimulated INS > 150 mIU/mL and low HDL OR 14.4; 95% CI 2.8–74.4; p = 0.001 OR 14.0; 95% CI 2.7–72.7; p = 0.001
OGTT stimulated INS > 150 mIU/mL and isolated OR 5.6; 95% CI 1.3–24.4; p = 0.02 OR 5.5; 95% CI 1.2–24.8; p = 0.02
diastolic hypertension
OGTT stimulated INS > 150 mIU/mL OR 10.3; 95% CI 1.95–54.5; p = 0.005 OR 11.6; 95% CI 2.0–68.1; p = 0.006
and metabolic syndrome
FIGR > 0.3 and isolated diastolic hypertension OR 5.4; 95% CI 1.0–28.3; p = 0.04 OR 6.2; 95% CI 0.9–40.6; p = 0.07
FIGR > 0.3 and metabolic syndrome OR 5.4; 95% CI 1.0–28.3; p = 0.04 OR 4.9; 95% CI 0.8–29.2; p = 0.07
INS — insulin; OGTT — oral glucose tolerance test; TG — triglycerides; low HDL — HDL cholesterol < 40 mg/dL in children aged 10–16, < 40 mg/dL
for boys above the age of 16, < 50 mg/dL for girls above the age of 16; FIGR — fasting insulin to glucose ratio
Table II. Correlation coefficients of hyperinsulinaemia and studied IR indices with metabolic disturbances, hypertension and
metabolic syndrome in 78 obese children and adolescents (42 girls, 36 boys)
Tabela II. Zależności pomiędzy hiperinsulinemią i wskaźnikami insulinooporności a zaburzeniami metabolicznymi,
nadciśnieniem i zespołem metabolicznym u 78 otyłych dzieci i młodzieży (42 dziewczęta, 36 chłopców)
Fasting INS OGTT stimulated INS FIGR R-HOMA
> 15 mIU/mL  > 150 mIU/mL > 0.3 >2.5
TC ≥ 200 mg/dL –0.27 0.31 0.23 –0.11
TG ≥ 150 mg/dL 0.30 0.57*** 0.63** 0.22
LDL ≥ 130 mg/dL –0.42* 0.08 –0.31 –0.32
Low HDL 0.56** 0.87*** 0.61** 0.1
Fasting GLU ≥ 100 mg/dL –0.18 0.33 –1.0 0.52
GLU 2-hours of OGTT ≥ 140 mg/dL –0.33 0.28 0.38 0.51*
Hypertension 0.70*** 0.53** 0.61** 0.78***
Isolated diastolic hypertension 0.76*** 0.70*** 0.69** 0.73**
Isolated systolic hypertension 0.65*** 0.45* 0.39 0.76**
WC ≥ 90th 0.14 0.38 –0.23 0.14
Metabolic syndrome 0.6** 0.82*** 0.69** 0.73**
* p < 0.05; ** p < 0.01; *** p < 0.001; TC — total cholesterol; TG — triglycerides; LDL — LDL cholesterol; low HDL — HDL cholesterol < 40 mg/dL
in children aged 10–16, < 40 mg/dL for boys above the age of 16, < 50 mg/dL for girls above the age of 16; GLU — glucose; OGTT — oral glucose
tolerance test; WC — waist circumference
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than without increased fasting INS level. This associa-
tion did not change significantly after adjusting for BMI
Z-score. Moreover, the increased fasting INS level was
associated with a significant increase in the risk of iso-
lated diastolic and systolic hypertension. The risk of iso-
lated diastolic hypertension was significantly associat-
ed also with stimulated hyperinsulinaemia and in-
creased FIGR. Significant associations between stimu-
lated hyperinsulinaemia and hypertriglyceridaemia and
low HDL level were found.
There was a significant association between stimu-
lated hyperinsulinaemia and increased FIGR and MS
occurrence. Moreover, the association between stimu-
lated hyperinsulinaemia and MS did not change signif-
icantly after adjusting for BMI Z-score.
The relative odds of obese children having MS com-
ponents did not increase significantly if BMI Z-score
≥ 2.5 or ≥ 3.0 was present. However, we found a sig-
nificant association between BMI Z-score ≥ 2.5 and
≥ .3.0 and MS occurrence (OR 4.6; 95% CI 1.1–19.8;
p = 0.024; OR 6.9; 95% CI 1.5–32.2; p = 0.01; respectively).
Discussion
Bacha et al. [17] demonstrated that despite similar BMI,
there are obese adolescents who are moderately INS
resistant and remain at lower risk of cardiovascular dis-
ease, and others who are severely INS resistant and are
at greater risk of obesity-related co-morbidities. In our
group of obese children and adolescents, 54% had fast-
ing or OGTT stimulated hyperinsulinaemia. The occur-
rence of the elevated fasting INS level in our study (41%)
was lower that the one noted by Galli-Tsinopoulou et
al. [18], who reported fasting hyperinsulinaemia in 54%
of obese children and up to 80% of obese adolescents.
If considered as a whole, hyperinsulinaemia and/or IR
were present in more than 70% of our patients.
BMI of all children was above the 97th percentile, but
the degree of their obesity was relatively wide (BMI
Z-score range 1.68–3.55). A significant association of the
increase in BMI percentile with IR, increased BP and
dyslipidaemia in children and adolescents has been re-
ported by other authors [19–22]. However, they stud-
ied this relationship in the whole population, not only
in obese subjects. In obese children and adolescents, the
data are confusing. Viner et al. [23] found no significant
relationship between severity of obesity and MS preva-
lence. On the other hand, Weiss et al. [19] and Sen et al.
[9] reported a significant association between the risk
of MS and severity of obesity.
The degree of obesity appears to be a poor predic-
tor of lipid values in obese children, and modest in obese
adolescents [24]. However, the risk of hypertension
seems to correlate with the severity of obesity [25]. In
our study, we found a linear relationship of BMI Z-score
with isolated systolic and diastolic BP. Severe and mor-
bid obesity (BMI Z-score ≥ 2.5) correlated significantly
with many components of MS, although these relation-
ships were weak or moderate. In children with morbid
obesity (BMI Z-score ≥ 3.0), these correlations became
stronger. However in logistic regression analysis, there
were no significant associations between the degree of
obesity and MS components. This could be because in
obese children and adolescents, BMI status is not
a straightforward determinant of glucose and lipid me-
tabolism disturbances as well as increased BP, because
of poor discrimination of a lean body mass from a fat
mass and fat distribution. On the other hand, BMI
Z-score correlated significantly with MS occurrence, as
there was a significant gamma correlation and associa-
tion in logistic regression analysis between BMI Z-score
≥ 2.5 and ≥ 3.0 and MS occurrence. These relationships
could be interdependent because of the correlation of
BMI Z-score with increased WC, and high WC is one of
the metabolic syndrome components required for a MS
diagnosis according to the IDF definition [13]. Addition-
ally, the risk of MS occurrence was 4.6 times higher in
obese subjects with a BMI Z-score ≥ 2.5, and 6.9 times
higher when BMI Z-score was ≥ 3.0. The increase of
risk related to increase of BMI Z-score is in agreement
with the results of other authors. Sen et al. [9] found
that a one point increase of BMI Z-score enhanced the
prevalence of MS by nearly double. Weiss et al. [19] cal-
culated that the risk of MS in obese children and ado-
lescents increased by 50% with every 0.5-unit increment
in the BMI Z-score.
There were weak correlations between a degree of
obesity expressed as BMI Z-score and fasting INS con-
centration and R-HOMA. The weakness of this relation-
ship may be due to the fact that BMI is considered by
many authors as not a very accurate index of visceral
fat content in a child’s body [26, 27]. The other reason
could be a genetically induced variability of IR and com-
pensatory hyperinsulinaemia in studied children. It is
also well known that fasting INS level is a rather weak
index of INS action disturbances and compensatory hy-
perinsulinaemia. The single measurement of fasting INS
level, among other reasons, is not reliable because of
the cyclicity of its basal secretion [11]. Indices of IR de-
rived from hyperinsulinaemic-euglycemic clamp stud-
ies and intravenous GLU tolerance test are much more
accurate, and they provide more information about INS
sensitivity of peripheral tissues [11]. Unfortunately these
methods are invasive, complex, expensive and time-
consuming. Clinicians therefore prefer simple tools such
as fasting or OGGT GLU and INS levels. Conwell et al.
[28], in a group of obese children and adolescents, ob-
served high correlations between fasting INS level and
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IR indices and INS sensitivity evaluated by intravenous
GLU tolerance test. Yeckel et al. [5] found that INS sen-
sitivity can be effectively estimated using indices de-
rived from OGTT.
It is believed that IR and hyperinsulinaemia are pro-
gressive and contribute to atherogenic serum lipid pro-
file [29–31]. In a state of IR and compensatory hyperin-
sulinaemia, hepatic synthesis of very-low-density lipo-
protein (VLDL), from increased free fatty acids output
from visceral fat tissue, is enhanced [30]. Consequently
it contributes to the increased plasma LDL and TG lev-
els [28]. Elevated VLDL-triacyloglycerol concentration
causes a decrease in HDL level [32]. We found strong
significant correlations between hyperinsulinaemia and/
/or elevated IR indices and increased TG and low HDL
levels. Moreover, the risk of hypertriglyceridaemia and
low HDL concentration were significantly higher if an
obese child had stimulated hyperinsulinaemia. Fasting
hyperinsulinaemia was associated with a 5.6 times higher
risk of hypertension, while OGTT stimulated hyperin-
sulinaemia increased by 3.7 times the risk of hypertrig-
lyceridaemia and by 14.4 times the risk of low HDL con-
centrations.
Similar results were published by Steinberger et al.
[33], who found a relationship between degree of IR
and increased TG and low HDL concentrations in obese
adolescents. The results of the study by Cruz et al. [32]
showed the associations between INS sensitivity and
HDL, TG and BP. Significant correlation between BMI
and fasting INS, as well as the strong influence of BMI
on association between fasting INS and HDL and TG
concentrations, was found by Sinaiko et al [34]. In our
study, despite significant correlation between BMI
Z-score and fasting INS level, and significant correlations
between increased TG concentration and BMI Z-score
≥ 2.5 and ≥ 3.0, the relationships between hypeinsuli-
naemia and IR indices and lipid abnormalities did not
change significantly after adjusting for BMI Z-score.
The relationship between IR and hypertension in
adults and children is well known but its mechanism is
unclear [35–37]. Nevertheless, IR or hyperinsulinaemia
are risk factors of hypertension and subjects with coex-
istence of elevated BP and IR are at greater risk of car-
diovascular disease [29]. In our study, we found corre-
lations between hyperinsulinaemia and/or elevated IR
indices and hypertension. In a logistic regression mod-
el, higher risk of diastolic hypertension was present
when increased fasting and stimulated INS level exist-
ed, even after adjusting for BMI Z-score.
Weiss et al. [19] reported a simple correlation be-
tween IR assessed by R-HOMA and the prevalence of
MS. Also, in a logistic regression model, increased
R-HOMA was associated with elevated risk of MS. In our
obese children, significantly strong correlations between
fasting and OGTT stimulated hyperinsulinaemia, in-
creased FIGR and R-HOMA and MS were also found.
When a logistic regression model was used, significant
associations between increased risk of MS in obese chil-
dren and adolescents with elevated stimulated INS level
and FIGR were found. The relationship between MS
occurrence and stimulated hyperinsulinaemia was sig-
nificant even after adjusting for BMI Z-score.
To conclude, our study shows that BMI Z-score, and
OGTT stimulated hyperinsulinaemia, are good predic-
tors of MS occurrence in obese children and adolescents.
However, hyperinsulinaemia and IR, but not the de-
gree of obesity, are the independent risk factors of dylip-
idaemia and hypertension.
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